Showing results (51-60 of 104) with videos related to
Sort By:
Pageof 11
Transportation Research Record|July 24, 2015
The Language of Driving: Advantages and Applications of Symbolic Data Reduction for Analysis of Naturalistic Driving DataAnthony D McDonald, John D Lee, Nazan S Aksan, et al.Biotechnology and Applied Biochemistry|December 17, 2011
Biochemical characterization of fluorescent-labeled recombinant human alpha-L-iduronidase in vitroBrigette L Tippin, Larisa Troitskaya, Shih-hsin Kan, et al.Transportation Research. Part F, Traffic Psychology and Behaviour|December 19, 2018
Using Topic Modeling to Develop Multi-level Descriptions of Naturalistic Driving Data from Drivers with and without Sleep ApneaElease J McLaurin, John D Lee, Anthony D McDonald, et al.CPT: Pharmacometrics & Systems Pharmacology|August 4, 2025
Assessing Cytochrome P450 Drug Interaction Risk for Dordaviprone Using Physiologically Based Pharmacokinetic ModelingSwati Jaiswal, Nikunjkumar K Patel, Hannah M Jones, et al.Nutrition and Cancer|July 22, 2011
High dietary niacin may increase prostaglandin formation but does not increase tumor formation in ApcMin/+ miceAlan M Kwong, Brigette L Tippin, Alicia M Materi, et al.Clinical Pharmacology in Drug Development|January 16, 2025
A Phase 1 Randomized Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Single Escalating Oral Doses of Dordaviprone and the Effects of Food on the Bioavailability of Dordaviprone in Healthy Adult SubjectsShamia L Faison, Joelle Batonga, Thangam Arumugham, et al.Journal of Pharmaceutical Sciences|September 7, 2004
In vitro absorption and secretory quotients: practical criteria derived from a study of 331 compounds to assess for the impact of P-glycoprotein-mediated efflux on drug candidatesVictoria E Thiel-Demby, Timothy K Tippin, Joan E Humphreys, et al.Neuropsychology|October 20, 1999
Depression in multiple sclerosis: relationship to working memory capacityP A Arnett, C I Higginson, W D Voss, et al.Journal of Clinical Pharmacology|November 22, 2024
Relative Bioavailability of Dordaviprone (ONC201) is Not Affected by Co-Administration of the Proton-Pump Inhibitor RabeprazoleShamia L Faison, Joelle Batonga, Thangam Arumugham, et al.Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 23, 2018
False-positive results released by direct-to-consumer genetic tests highlight the importance of clinical confirmation testing for appropriate patient careStephany Tandy-Connor, Jenna Guiltinan, Kate Krempely, et al.Pageof 11